Patients who should not receive BPC-157 include: those with active or recent malignancies (due to angiogenic concerns), pregnant or breastfeeding women (no reproductive toxicology data in humans), patients on anticoagulation therapy (theoretical bleeding risk from angiogenesis at ulcer sites), and minors (no pediatric data of any kind)
Most published work is in rodent models
Avoid selfsourcing, untested vials, and multimonth cycles without medical monitoring
Vegans and Vegetarians Since Vitamin B12 is primarily found in animal products, plant-based diets may lack adequate levels
How penta deca peptide arginate differs from standard BPC-157 The core amino acid sequence is identical
Publisher FDA Accessed Jun 27, 2026 Study type Regulatory Document Limitations: Regulatory language is product-, jurisdiction- and use-specific